<DOC>
	<DOCNO>NCT00703482</DOCNO>
	<brief_summary>The purpose study study effect different combination fenofibrate coenzyme Q10 ventricular diastolic function patient Type II diabetes</brief_summary>
	<brief_title>A Randomised , Double-Blind , Placebo-Controlled Study Assessing Effect Fenofibrate , Coenzyme Q10 Their co-Administration Ventricular Diastolic Function Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Men woman age 40 79 year Patients preexist T2DM HbA1C &lt; 9 % Written informed consent unable comply protocol , Likely leave trial completion participate another trial 3Ã  day V1 Pregnant childbearing potential use birth control method Type 1 diabetic patient , T2Dm insulin therapy Patients one follow pathology : muscular disorder know increase CK , hepatic deficiency transaminase increase symptomatic gallbladder disease or/and renal insufficiency abnormal thyroid function proliferative retinopathy recent cardiovascular event , uncontrolled hypertension know chronic alcohol intake severe pathology TC &gt; = 7.0 mmol/L and/or TG &gt; = 4mmol/L V1 Patients treat Warfarin Patients specific ECG dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Ventricular diastolic Function</keyword>
	<keyword>Diabetes</keyword>
</DOC>